In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Start-Up Previews, November 2013

Executive Summary

This Month's Profile Group: Heightened Concussion Awareness Calls For New Detection Tools, features profiles of Cerora, MC10, Oculogica, and Sway Medical. Plus these Start-Ups Across Health Care: Bicycle Therapeutics, Crosstrees Medical, Rescue Therapeutics, and Sensulin.

You may also be interested in...

Crosstrees Medical Inc.

Forget about inflating balloons to treat vertebral fractures: the PVA Pod System from Crosstrees Medical Inc. is a woven-fabric container that is positioned in the spine, and enables orthopedic surgeons or interventional radiologists to precisely control delivery of cement while reducing the threat of cement leakage.

Sway Medical LLC

Sway Medical LLC hopes to bring an objective and inexpensive tool for the assessment of concussions to the playing field. Its Sway Balance system combines the hardware that is built into every iPhone with Sway’s proprietary software to assess players’ balance – a well-accepted measure for diagnosing concussion and measuring recovery from concussion – from the sidelines.

MC10 Inc.

MC10’s wearable Biostamp, an extremely thin sensing patch akin to an artificial tattoo, has myriad applications in consumer and medical device markets. The start-up’s first product, launched in collaboration with Reebok International, is the CheckLight for detecting potential concussions in athletes who participate in contact sports.

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts